ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Ionis-backed Dynacure bags €47M to start clinical trials
fiercebiotech
July 09, 2018Dynacure has raised €47 million ($55 million) to take an antisense oligonucleotide therapy into the clinic. The French biotech picked up the centronuclear myopathy (CNM) prospect from its cofounder, Ionis Pharmaceuticals.
Pharma Sources Insight January 2025
